The tanning peptide that never made it —
and the two drugs that did.

Melanotan II's structure was published in journals and patents, then orphaned by its own developers. Once the recipe was public and the demand was real, the gray market was only a matter of time.

Two peptides from the same Arizona lab, almost the same molecule. One became an approved medicine. The other became the gray market's favorite. The difference is a lesson in selectivity.

The strangest chapter in the Melanotan story: a University of Arizona self-experiment that produced an eight-hour erection — and pointed the way to an FDA-approved libido drug.

A tan is the body's own sunscreen: eumelanin absorbing ultraviolet before it reaches DNA. Understanding how melanin protects — and how little — is the key to what Melanotan was reaching for.

A suntan is a wound response — pigment the skin makes only after ultraviolet has already damaged its DNA. Melanotan's elegant idea was to get the pigment without the damage that normally triggers it.

Red hair, freckles, and burning instead of tanning all trace to one receptor: MC1R. It's the same keyhole every Melanotan was cut to fit — and a melanoma risk gene in its own right.

Why is a tan so hard to give up? UV light makes your skin manufacture a real opioid. The addiction science — mice, naloxone, and eight frequent tanners — and what it explains about a peptide.

Melanotan II never went away — it went viral. Nasal sprays, flavored drops, and the 'vacation peptide' on TikTok. How social media re-packaged an unregulated injectable, and the regulatory gap that lets it sell in the open.

Melanotan II may be the most self-injected drug no regulator ever approved. The reason isn't only lax enforcement — it's that it served a want, not a need, and wants don't wait for clinical trials.

Melanotan II darkens and multiplies moles — and the deeper danger is diagnostic. The case reports, the unresolved melanoma question, and why a changing mole is the exact signal you don't want to lose.

Separating what Melanotan II reliably does from forum lore and worst-case rumor: the acute effects, the pigment effects, and the rare serious events that actually reach the medical literature.

Gray-market Melanotan II is an unregulated injectable, made by unknown labs and reconstituted at the kitchen table. Purity, sterility, and dose are all assumptions — and assumptions have sent people to the ER.

GLP-1 reached the masses through diabetes first. A photoprotective melanocortin drug has its own candidate beachheads — and one of them, vitiligo, is in Phase III right now.

A drug that prevents skin cancer in healthy people would need one of the longest, largest, most expensive trials in medicine. Why the evidence bar — not the chemistry — is the real wall.

Melanotan II is illegal in America — but the technology it previewed is not. A primer on the U.S. regulatory landscape (FDA approval, compounding, and the gray market) for the melanocortin agonists that give skin photoprotection without the sun.

Not a vial from a forum — a real one. The four things a general-public photoprotective drug would need to clear, and how far today's science already is toward each. Analysis, labeled as such.